HYPERION DEFI, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
HYPERION DEFI, INC. (HYPD) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 50.50 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2026-03-30
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-12-31 was 0.00 shares.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-09-30 was 8.50K shares.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2023-12-31 was 0.00 shares.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2023-09-30 was 0.00 shares.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2025 was 50.50K shares.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2023 was 22.22K shares, a 219.14% increase from fiscal 2022.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2022 was 6.96K shares, a 0.00% change from fiscal 2021.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2021 was 6.96K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 8.50K shares derived: sum of 2 quarters · filed 2026-03-30 | 50.50K shares 10-K · filed 2026-03-30 | |
| 2025-09-30 | 8.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 50.50K shares 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | 42.00K shares 10-Q · filed 2025-08-13 | |||
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | 0.00 shares derived: sum of 2 quarters · filed 2024-03-18 | 0.00 shares derived: sum of 3 quarters · filed 2024-03-18 | 22.22K shares 10-K · filed 2024-03-18 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-13 | 22.22K shares 10-Q · filed 2023-11-13 | 22.22K shares derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | 22.22K shares 10-Q · filed 2023-08-11 | 22.22K shares derived: sum of 3 quarters · filed 2023-08-11 | 22.22K shares derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | 22.22K shares 10-Q · filed 2023-05-12 | 22.22K shares derived: sum of 2 quarters · filed 2023-05-12 | 22.22K shares derived: sum of 3 quarters · filed 2023-05-12 | 22.22K shares derived: sum of 4 quarters · filed 2023-05-12 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-31 | 0.00 shares derived: sum of 3 quarters · filed 2023-03-31 | 6.96K shares 10-K · filed 2023-03-31 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2022-11-14 | 6.96K shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 6.96K shares 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | 6.96K shares 10-Q · filed 2022-05-13 | |||
| 2021-12-31 | 6.96K shares 10-K · filed 2022-03-30 | |||
| 2017-12-31 | 0.00 shares 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |